Cipla shares slipped as much as 4.6% on Friday to hit an intraday low of Rs 1,367.8 apiece on the BSE after the company temporarily paused manufacturing of Lanreotide Injection, one of its top three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results